BCSCDB: Biomarkers of Cancer Stem Cells Database
Number of interactions with MDA-MB-231 is 100
| INTERACTOR1 | INT1_HGNC_ID | INTERACTOR2 | INT2_HGNC_ID | INTERACTION_TYPE | CSC_METHOD | CANCER_TYPE | HISTOLOGICAL_TYPE | CELL_LINE | INTERACTION_METHOD | EXPRESSION_LEVEL | PUBMED_ID |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CTNNB1 | 2514 | ALDH1A1 | 402 | Protein-Gene Interaction | NA | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-231 | ChIP assay | Up | 33797754 |
| BOP1 | 15519 | ALDH1A1 | 402 | Protein-Gene Interaction | NA | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-231 | ChIP assay | Up | 33797754 |
| TWIST1 | 12428 | PDGFRB | 8804 | Protein-Gene Interaction | NA | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-231 | Luciferase Reporter assay followed by ChIP assay | Up | 33845139 |
| STUB1 | 11427 | POU5F1 | 9221 | Gene-Gene Interaction | NA | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-231 | SiRNA mediated knockdown of STUB1 followed by RT-PCR | Up | 29511337 |
| CTNNB1 | 2514 | PROM1 | 9454 | Protein-Gene Interaction | NA | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-231 | ChIP assay | Up | 33797754 |
| BOP1 | 15519 | PROM1 | 9454 | Protein-Gene Interaction | NA | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-231 | ChIP assay | Up | 33797754 |
| SOX9 | 11204 | ALDH1A3 | 409 | Protein-Gene Interaction | NA | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-231 | ChIP assay | NA | 30622340 |
| CEBPD | 1835 | ATF4 | 786 | Protein-Protein Interaction | SFA | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-231 | Co-IP assay | NA | 29601799 |
| POU5F1 | 9221 | ATF4 | 786 | Protein-Protein Interaction | SFA | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-231 | Co-IP assay | NA | 29601799 |
| SOX2 | 11195 | ATF4 | 786 | Protein-Protein Interaction | SFA | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-231 | Co-IP assay | NA | 29601799 |
| POU5F1 | 9221 | ATF6 | 791 | Protein-Protein Interaction | SFA | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-231 | Co-IP assay | NA | 29601799 |
| SOX2 | 11195 | ATF6 | 791 | Protein-Protein Interaction | SFA | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-231 | Co-IP assay | NA | 29601799 |
| EZH2 | 3527 | BMI1 | 1066 | Protein-Gene Interaction | SFA | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-231 | ChIP assay | NA | 28914785 |
| HSP90AA1 | 5253 | BMI1 | 1066 | Protein-Gene Interaction | SFA | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-231 | ChIP assay | NA | 28914785 |
| MYC | 7553 | BMI1 | 1066 | Protein-Gene Interaction | SFA | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-231 | ChIP assay followed by qPCR | NA | 28914785 |
| SOX2 | 11195 | CCND1 | 1582 | Protein-Gene Interaction | NA | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-231 | ChIP assay | NA | 30622340 |
| BOP1 | 15519 | CREBBP | 2348 | Protein-Protein Interaction | NA | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-231 | Co-IP assay followed by Western Blotting | NA | 33797754 |
| ACTN4 | 166 | CTNNB1 | 2514 | Protein-Protein Interaction | NA | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-231 | Co-IP assay | NA | 29197410 |
| BOP1 | 15519 | CTNNB1 | 2514 | Protein-Protein Interaction | NA | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-231 | Co-IP assay followed by Western Blotting | NA | 33797754 |
| DROSHA | 17904 | CTNNB1 | 2514 | Protein-Protein Interaction | NA | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-231 | Co-IP assay followed by Western Blotting | NA | 32859993 |
| ZNF326 | 14104 | DACH1 | 2663 | Protein-Gene Interaction | SFA | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-231 | ChIP assay followed by Luciferase Reporter assay | NA | 29187406 |
| ZNF326 | 14104 | GATA3 | 4172 | Protein-Gene Interaction | SFA | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-231 | ChIP assay followed by Luciferase Reporter assay | NA | 30021199 |
| ZNF32 | 13095 | GPER1 | 4485 | Protein-Gene Interaction | NA | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-231 | ChIP followed by qPCR | NA | 30478301 |
| EZH2 | 3527 | HSP90AA1 | 5253 | Protein-Protein Interaction | SFA | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-231 | Co-IP assay | NA | 28914785 |
| MYC | 7553 | HSP90AA1 | 5253 | Protein-Protein Interaction | SFA | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-231 | Co-IP assay followed by Western Blotting | NA | 28914785 |
| NFKB1 | 7794 | IL6 | 6018 | Protein-Gene Interaction | SFA | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-231 | ChIP assay followed by qPCR | NA | 29073729 |
| PAK1 | 8590 | IL6 | 6018 | Protein-Gene Interaction | NA | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-231 | ChIP assay followed by qRT-PCR | NA | 31658701 |
| STAT3 | 11364 | IL6 | 6018 | Protein-Gene Interaction | NA | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-231 | ChIP assay followed by qRT-PCR | NA | 31658701 |
| NFKB1 | 7794 | IL8 | 6025 | Protein-Gene Interaction | SFA | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-231 | ChIP assay followed by qPCR | NA | 29073729 |
| PAK1 | 8590 | JAK2 | 6192 | Protein-Protein Interaction | SFA | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-231 | Co-IP assay followed by Western Blotting | NA | 31658701 |
| VEGFA | 12680 | NRP1 | 8004 | Protein-Protein Interaction | SFA | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-231 | Co-IP followed by Western Blotting | NA | 29179185 |
| WASF3 | 12734 | YBX1 | 8014 | Protein-Protein Interaction | NA | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-231 | Co-IP assay followed by Western Blotting | NA | 29262622 |
| STUB1 | 11427 | POU5F1 | 9221 | Protein-Protein Interaction | SFA | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-231 | Co-IP assay | NA | 29511337 |
| GJB2 | 4284 | PTK2 | 9611 | Protein-Protein Interaction | SFA | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-231 | Co-IP assay | NA | 30597041 |
| CEBPD | 1835 | SOX2 | 11195 | Protein-Protein Interaction | SFA | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-231 | Co-IP assay | NA | 29601799 |
| FOXM1 | 3818 | SOX2 | 11195 | Protein-Gene Interaction | SFA | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-231 | ChIP assay followed by qPCR | NA | 31296961 |
| FOXO3 | 3821 | SOX2 | 11195 | Protein-Gene Interaction | SFA | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-231 | ChIP assay followed by qPCR | NA | 31296961 |
| SOX2 | 11195 | SOX9 | 11204 | Protein-Gene Interaction | NA | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-231 | ChIP assay | NA | 30622340 |
| PAK1 | 8590 | STAT3 | 11364 | Protein-Protein Interaction | SFA | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-231 | Co-IP assay followed by Western Blotting | NA | 31658701 |
| DNMT3B | 2979 | ZEB1 | 11642 | Protein-Protein Interaction | NA | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-231 | Co-IP assay | NA | 28903350 |
| HDAC1 | 4852 | ZEB1 | 11642 | Protein-Protein Interaction | NA | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-231 | Co-IP assay | NA | 28903350 |
| TAFAZZIN | 11577 | TEAD1 | 11714 | Protein-Protein Interaction | NA | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-231 | Co-IP assay | NA | 30479839 |
| POU5F1 | 9221 | XBP1 | 12801 | Protein-Protein Interaction | SFA | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-231 | Co-IP assay | NA | 29601799 |
| DNMT1 | 2976 | BCL11A | 13221 | Protein-Protein Interaction | SFA | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-231 | Co-IP assay followed by Western Blotting | NA | 31604679 |
| DNMT3B | 2979 | NEUROG3 | 13806 | Protein-Gene Interaction | NA | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-231 | ChIP assay | NA | 28903350 |
| HDAC1 | 4852 | NEUROG3 | 13806 | Protein-Gene Interaction | NA | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-231 | ChIP assay | NA | 28903350 |
| LINC01133 | 49447 | FOXP2 | 13875 | Protein-Gene Interaction | SFA | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-231 | ChIP assay | NA | 30613295 |
| ZNF326 | 14104 | KLF17 | 18830 | Protein-Gene Interaction | SFA | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-231 | ChIP assay followed by Luciferase Reporter assay | NA | 31283068 |
| GJB2 | 4284 | NANOG | 20857 | Protein-Protein Interaction | SFA | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-231 | Co-IP assay | NA | 30597041 |
| HSPA9 | 5244 | ABCG2 | 74 | Gene-Gene Interaction | NA | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-231 | SiRNA mediated knockdown of HSPA9 followed by qRT-PCR | Down | 34249423 |
| MIR203A | 31581 | AKT1 | 391 | miRNA-mRNA Interaction | NA | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-231 | Transfection with MIR203 mimics followed by Luciferase Reporter assay and qRT-PCR | Down | 33576006 |
| MIR203A | 31581 | ALDH1A1 | 402 | miRNA-mRNA Interaction | NA | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-231 | Transfection with MIR203 mimics followed by Luciferase Reporter assay and qRT-PCR | Down | 33576006 |
| PKD3 | NA | ALDH1A1 | 402 | Gene-Gene Interaction | NA | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-231 | ShRNA mediated knockdown of PKD3 followed by qPCR | Down | 31745977 |
| MIR181A1 | 31590 | ATG5 | 589 | miRNA-mRNA Interaction | SFA | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-231 | Transfection with MIR181A1 mimics followed by Dual Luciferase Reporter assay and qRT-PCR | Down | 35029026 |
| SOX2 | 11195 | AXIN2 | 904 | Gene-Gene Interaction | NA | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-231 | ShRNA mediated knockdown of SOX2 followed by qPCR | Down | 30622340 |
| SOX9 | 11204 | AXIN2 | 904 | Gene-Gene Interaction | NA | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-231 | ShRNA mediated knockdown of SOX9 followed by qPCR | Down | 30622340 |
| NFE2L2 | 7782 | BMI1 | 1066 | Gene-Gene Interaction | SFA | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-231 | ShRNA mediated knockdown of NFE2L2 followed by RT-PCR | Down | 31672029 |
| WNT10B | 12775 | CD44 | 1681 | Gene-Gene Interaction | NA | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-231 | ShRNA mediated knockdown of WNT10B followed by RT-PCR | Down | 35413424 |
| MIR203A | 31581 | CD44 | 1681 | miRNA-mRNA Interaction | NA | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-231 | Transfection with MIR203 mimics followed by Luciferase Reporter assay and qRT-PCR | Down | 33576006 |
| PKD3 | NA | CD44 | 1681 | Gene-Gene Interaction | NA | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-231 | ShRNA mediated knockdown of PKD3 followed by qPCR | Down | 31745977 |
| MIR708 | 33654 | CD47 | 1682 | miRNA-mRNA Interaction | SFA | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-231 | Transfection with MIR708 mimics followed by Luciferase Reporter assay | Down | 31273952 |
| MIR139 | 31526 | CXCR4 | 2561 | miRNA-mRNA Interaction | NA | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-231 | Transfection with MIR139 mimics followed by Dual Luciferase Reporter assay and qRT-PCR | Down | 34070538 |
| MIR185 | 31556 | E2F1 | 3113 | miRNA-mRNA Interaction | SFA | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-231 | Luciferase Reporter assay followed by RT-PCR | Down | 30262865 |
| MIR4319 | 38212 | E2F2 | 3114 | miRNA-mRNA Interaction | SFA | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-231 | Transfection with MIR4319 mimics followed by Luciferase Reporter assay and Western Blotting | Down | 31300015 |
| MIR526B | 32100 | EPAS1 | 3374 | miRNA-mRNA Interaction | NA | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-231 | Transfection with MIR526B mimics followed by Luciferase Reporter assay and qPCR | Down | 35004266 |
| MIR1-1 | 31499 | MECOM | 3498 | miRNA-mRNA Interaction | FACs for CSC marker | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-231 | Transfection with MIR130A mimics followed by Luciferase Reporter assay and RT-PCR | Down | 30584335 |
| SOX9 | 11204 | FZD4 | 4042 | Gene-Gene Interaction | NA | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-231 | ShRNA mediated knockdown of SOX9 followed by qPCR | Down | 30622340 |
| NFE2L2 | 7782 | GCLC | 4311 | Gene-Gene Interaction | SFA | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-231 | ShRNA mediated knockdown of NFE2L2 followed by RT-PCR | Down | 31672029 |
| CXCR4 | 2561 | GLI1 | 4317 | Gene-Gene Interaction | NA | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-231 | SiRNA mediated knockdown of CXCR4 followed by qRT-PCR | Down | 34052833 |
| WNT10B | 12775 | HMGA2 | 5009 | Gene-Gene Interaction | NA | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-231 | ShRNA mediated knockdown of WNT10B followed by RT-PCR | Down | 35413424 |
| WNT10B | 12775 | INHBB | 6067 | Gene-Gene Interaction | NA | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-231 | ShRNA mediated knockdown of WNT10B followed by RT-PCR | Down | 35413424 |
| WNT10B | 12775 | JUN | 6204 | Gene-Gene Interaction | NA | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-231 | ShRNA mediated knockdown of WNT10B followed by RT-PCR | Down | 35413424 |
| WNT10B | 12775 | MET | 7029 | Gene-Gene Interaction | NA | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-231 | ShRNA mediated knockdown of WNT10B followed by RT-PCR | Down | 35413424 |
| PKD3 | NA | NOTCH4 | 7884 | Gene-Gene Interaction | NA | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-231 | ShRNA mediated knockdown of PKD3 followed by qPCR | Down | 31745977 |
| MIR203A | 31581 | PDK1 | 8809 | miRNA-mRNA Interaction | NA | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-231 | Transfection with MIR203 mimics followed by Luciferase Reporter assay and qRT-PCR | Down | 33576006 |
| HSPA9 | 5244 | POU5F1 | 9221 | Gene-Gene Interaction | NA | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-231 | SiRNA mediated knockdown of HSPA9 followed by qRT-PCR | Down | 34249423 |
| LDHA | 6535 | POU5F1 | 9221 | Gene-Gene Interaction | NA | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-231 | ShRNA mediated knockdown of LDHA followed by qRT-PCR | Down | 34178639 |
| YAP1 | 16262 | POU5F1 | 9221 | Gene-Gene Interaction | NA | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-231 | SiRNA mediated knockdown of YAP1 followed by qRT-PCR | Down | 34146553 |
| PKD3 | NA | POU5F1 | 9221 | Gene-Gene Interaction | NA | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-231 | ShRNA mediated knockdown of PKD3 followed by qPCR | Down | 31745977 |
| WNT10B | 12775 | PROM1 | 9454 | Gene-Gene Interaction | NA | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-231 | ShRNA mediated knockdown of WNT10B followed by RT-PCR | Down | 35413424 |
| PKD3 | NA | SNAI1 | 11128 | Gene-Gene Interaction | NA | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-231 | ShRNA mediated knockdown of PKD3 followed by qPCR | Down | 31745977 |
| MIR628 | 32884 | SOS1 | 11187 | miRNA-mRNA Interaction | FACs for CSC marker | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-231 | Transfection with MIR628 mimics followe by Luciferase Reporter assay | Down | 30262865 |
| LDHA | 6535 | SOX2 | 11195 | Gene-Gene Interaction | NA | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-231 | ShRNA mediated knockdown of LDHA followed by qRT-PCR | Down | 34178639 |
| YAP1 | 16262 | SOX2 | 11195 | Gene-Gene Interaction | NA | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-231 | SiRNA mediated knockdown of YAP1 followed by qRT-PCR | Down | 34146553 |
| PKD3 | NA | SOX2 | 11195 | Gene-Gene Interaction | NA | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-231 | ShRNA mediated knockdown of PKD3 followed by qPCR | Down | 31745977 |
| MIR30A | 31624 | SOX4 | 11200 | miRNA-mRNA Interaction | NA | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-231 | Transfection with MIR30A mimics followed by Luciferase Reporter assay and qRT-PCR | Down | 34234874 |
| SOX2 | 11195 | SOX9 | 11204 | Gene-Gene Interaction | NA | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-231 | ShRNA mediated knockdown of SOX2 followed by qPCR | Down | 30622340 |
| MIR365A | 33692 | STAT3 | 11364 | miRNA-mRNA Interaction | NA | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-231 | Transfection with MIR365A mimics followed by Luciferase Reporter assay and qPCR | Down | 34789263 |
| WNT10B | 12775 | TGFB2 | 11768 | Gene-Gene Interaction | NA | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-231 | ShRNA mediated knockdown of WNT10B followed by RT-PCR | Down | 35413424 |
| MIR140 | 31527 | WNT1 | 12774 | miRNA-mRNA Interaction | SFA | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-231 | Transfection with MIR140 mimics followed by Luciferase Reporter assay | Down | 31300015 |
| MIR365A | 33692 | NOLC1 | 15608 | miRNA-mRNA Interaction | NA | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-231 | Transfection with MIR365A mimics followed by Luciferase Reporter assay and qPCR | Down | 34789263 |
| MIR181A1 | 31590 | ATG2B | 20187 | miRNA-mRNA Interaction | SFA | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-231 | Transfection with MIR181A1 mimics followed by Dual Luciferase Reporter assay and qRT-PCR | Down | 35029026 |
| LDHA | 6535 | NANOG | 20857 | Gene-Gene Interaction | NA | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-231 | ShRNA mediated knockdown of LDHA followed by qRT-PCR | Down | 34178639 |
| MIR203A | 31581 | NANOG | 20857 | miRNA-mRNA Interaction | NA | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-231 | Transfection with MIR203 mimics followed by Luciferase Reporter assay and qRT-PCR | Down | 33576006 |
| MIR30A | 31624 | NANOG | 20857 | miRNA-mRNA Interaction | SFA | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-231 | Transfection with MIR30A mimics followed by Luciferase Reporter assay and RT-PCR | Down | 29797562 |
| PKD3 | NA | NANOG | 20857 | Gene-Gene Interaction | NA | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-231 | ShRNA mediated knockdown of PKD3 followed by qPCR | Down | 31745977 |
| MIR34A | 31635 | RTCB | 26935 | miRNA-mRNA Interaction | SFA | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-231 | Transfection with MIR34A mimics followed by Luciferase Reporter assay | Down | 29187905 |
| MIR34A | 31635 | RTCB | 26935 | miRNA-mRNA Interaction | SFA | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-231 | Transfection with MIR34A mimics followed by qRT-PCR | Down | 29187905 |
| MIR30A | 31624 | FEZF1-AS1 | 41001 | miRNA-mRNA Interaction | SFA | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-231 | Transfection with MIR30A mimics followed by Luciferase Reporter assay and RT-PCR | Down | 29797562 |
| MIR185 | 31556 | LINC00511 | 43564 | miRNA-mRNA Interaction | SFA | Triple Negative Breast Cancer | Adenocarcinoma | MDA-MB-231 | Luciferase Reporter assay | Down | 30262865 |